Johnson & Johnson's 2nd-quarter sales top forecasts, prompting the medical product giant to raise its full-year earnings guidance.
Nobel Biocare doubles its 2nd-quarter profits as it reportedly fields interest – and at least 1 offer worth $2.3 billion – from potential acquirers.
ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.
Medtronic's fiscal 1st-quarter earnings beat Wall Street's forecast by a penny on a modest single-digit sales increase.
Diabetes devices maker DexCom gets some Wall Street love after gaining major momentum in the 2nd quarter.
Diabetes devices maker DexCom (NSDQ:DXCM) got a lot of love from Wall Street after issuing its latest quarterly report, with DXCM shares gaining 14.5% since last week.
Weight-loss implant EnteroMedics falls short of analysts' expectations during its 2nd quarter as the company continues to pursue FDA approval of its flagship Maestro nerve-stimulation device.
Minnesota-based EnteroMedics (NSDQ:ETRM) gained modestly this week after announcing its latest financial report, even though the company missed the mark by a penny.
CareFusion gains a couple points after posting a Street-beating 4th quarter and announcing a $750 million share repurchase program.
CareFusion (NYSE:CFN) posted a stellar 4th-quarter, posting double-digit growth in revenues and earnings and beating Wall Street's estimates.